Azelead works on therapeutic fields such as:
Oncology, infection, neurological disorders, toxicity, ecotoxicology and rare diseases.
Zebrascreen
Fast and accurate evaluation of the efficacy of a drug
Zebratox
An innovative methodology
Rapid and accurate assessment of the impact of a drug
on cell populations and on the development of the zebrafish embryo
Oncology
— ONCO-Platform
— Xenotransplantation models
— Metastasis model
— High content screening
Infection
— Infection models (P1 / P2 / P3)
(in collaboration with Cemipai)
— Real-time imaging
(immune and pathogenic cells)
— High content screening
Neurological Disorders
— Blood-brain barrier
— Microglia
— Behavioral analysis
— Neurotoxic
Toxicity
Acute toxicity
Nervous System Development
— Cardiac development
(in collaboration with Physiostyme)
— Hematopoiesis and vessel development
— Ototoxicity
(in collaboration with CILcare)
Ecotoxicology
FET OCDE 236
— Embryo survival
— Coagulation of fertilized eggs
— Failure to form somites
— Failure to detach the tail bud
— Heartbeat failure
— LC50
Rare diseases
— Edition
— Transgenesis
— Inactivation of genes
— Characterization